Bioventus (BVS) Tax Provisions (2020 - 2026)

Bioventus (BVS) has reported Tax Provisions for 7 consecutive years, with -$20.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Provisions fell 2107.4% year-over-year to -$20.9 million; the trailing twelve-month figure through Jun 2026 stood at -$22.8 million (down 1195.3% YoY), and the FY2025 full-year result was -$1.6 million, up 70.43% from the prior year.
• Tax Provisions eased to -$20.9 million in Q2 2026 per BVS's latest filing, from $571000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $1.2 million in Q3 2022 and bottomed at -$29.5 million in Q4 2022.
• Historically, Tax Provisions has averaged -$4.0 million across 5 years, with a median of $143000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions sank 6930.14% in 2022, then jumped 721.23% in 2024.
• Over 5 years, Tax Provisions stood at -$11.0 million in 2022, then surged by 93.16% to -$750000.0 in 2023, then jumped by 173.33% to $550000.0 in 2024, then tumbled by 677.27% to -$3.2 million in 2025, then slumped by 558.17% to -$20.9 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered -$20.9 million, $571000.0, and -$3.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.